CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 593.24 Thousand USD | 598.21% |
| 2020 | 84.96 Thousand USD | -98.29% |
| 2019 | 4.98 Million USD | -22.78% |
| 2018 | 6.45 Million USD | 25.76% |
| 2017 | 5.13 Million CAD | 177.85% |
| 2016 | 1.84 Million CAD | 1545.32% |
| 2015 | -127.75 Thousand USD | -200.47% |
| 2014 | 127.15 Thousand CAD | -16.22% |
| 2013 | 151.78 Thousand CAD | -29.16% |
| 2012 | 214.25 Thousand CAD | 37.71% |
| 2011 | 155.58 Thousand CAD | 0.44% |
| 2010 | 154.9 Thousand CAD | 5.74% |
| 2009 | 146.49 Thousand CAD | -38.72% |
| 2008 | 239.06 Thousand CAD | -61.17% |
| 2007 | 615.68 Thousand CAD | -10.61% |
| 2006 | 688.77 Thousand CAD | 68.68% |
| 2005 | 408.32 Thousand CAD | 78.46% |
| 2004 | 228.8 Thousand CAD | -10.49% |
| 2003 | 255.6 Thousand CAD | 16.31% |
| 2002 | 219.76 Thousand CAD | 128.72% |
| 2001 | 96.08 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | 108.69 Thousand USD | -24.22% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q1 | 143.42 Thousand USD | -32.0% |
| 2022 Q3 | 109.76 Thousand USD | 0.99% |
| 2022 FY | - USD | -100.0% |
| 2021 Q2 | -116.97 Thousand USD | -136.54% |
| 2021 Q1 | 320.08 Thousand USD | 169.91% |
| 2021 Q3 | 179.2 Thousand USD | 253.2% |
| 2021 Q4 | 210.92 Thousand USD | 17.7% |
| 2021 FY | 593.24 Thousand USD | 598.21% |
| 2020 Q2 | 107.46 Thousand USD | -58.7% |
| 2020 Q3 | 175.17 Thousand USD | 63.01% |
| 2020 Q4 | -457.84 Thousand USD | -361.37% |
| 2020 FY | 84.96 Thousand USD | -98.29% |
| 2020 Q1 | 260.17 Thousand USD | -75.53% |
| 2019 FY | 4.98 Million USD | -22.78% |
| 2019 Q4 | 1.06 Million USD | 342.03% |
| 2019 Q3 | 240.51 Thousand USD | -85.28% |
| 2019 Q1 | 2.04 Million USD | -43.83% |
| 2019 Q2 | 1.63 Million USD | -20.06% |
| 2018 Q4 | 3.63 Million USD | 701.44% |
| 2018 Q3 | 454.13 Thousand CAD | -66.0% |
| 2018 Q2 | 1.33 Million CAD | 61.58% |
| 2018 Q1 | 826.67 Thousand CAD | -50.75% |
| 2018 FY | 6.45 Million USD | 25.76% |
| 2017 Q1 | 1.56 Million CAD | 1539.37% |
| 2017 Q3 | 803.15 Thousand CAD | -12.44% |
| 2017 Q4 | 1.67 Million CAD | 108.98% |
| 2017 FY | 5.13 Million CAD | 177.85% |
| 2017 Q2 | 917.31 Thousand CAD | -41.55% |
| 2016 FY | 1.84 Million CAD | 1545.32% |
| 2016 Q4 | -109.04 Thousand USD | 91.41% |
| 2016 Q3 | -1.26 Million USD | -2963.56% |
| 2016 Q1 | -33 Thousand USD | 2.14% |
| 2016 Q2 | -41.43 Thousand USD | -25.53% |
| 2015 Q3 | 40.69 Thousand CAD | 44.32% |
| 2015 Q4 | -33.73 Thousand USD | -182.89% |
| 2015 Q2 | 28.19 Thousand CAD | 5.08% |
| 2015 Q1 | 26.83 Thousand CAD | -11.03% |
| 2015 FY | -127.75 Thousand USD | -200.47% |
| 2014 Q2 | 39.74 Thousand CAD | 56.96% |
| 2014 Q3 | 33.92 Thousand CAD | -14.64% |
| 2014 Q4 | 30.15 Thousand CAD | -11.11% |
| 2014 FY | 127.15 Thousand CAD | -16.22% |
| 2014 Q1 | 25.32 Thousand CAD | -27.53% |
| 2013 Q2 | 44.13 Thousand CAD | 23.6% |
| 2013 FY | 151.78 Thousand CAD | -29.16% |
| 2013 Q4 | 34.94 Thousand CAD | -4.56% |
| 2013 Q3 | 36.61 Thousand CAD | -17.04% |
| 2013 Q1 | 35.7 Thousand CAD | -40.9% |
| 2012 FY | 214.25 Thousand CAD | 37.71% |
| 2012 Q3 | 56.56 Thousand CAD | -0.98% |
| 2012 Q4 | 60.41 Thousand CAD | 6.8% |
| 2012 Q1 | 37.73 Thousand CAD | -35.42% |
| 2012 Q2 | 57.12 Thousand CAD | 51.36% |
| 2011 Q1 | 46.3 Thousand CAD | -18.43% |
| 2011 Q2 | 24.29 Thousand CAD | -47.53% |
| 2011 Q3 | 31.09 Thousand CAD | 27.98% |
| 2011 FY | 155.58 Thousand CAD | 0.44% |
| 2011 Q4 | 58.43 Thousand CAD | 87.92% |
| 2010 Q4 | 56.76 Thousand CAD | 76.13% |
| 2010 Q3 | 32.23 Thousand CAD | -0.71% |
| 2010 FY | 154.9 Thousand CAD | 5.74% |
| 2010 Q2 | 32.46 Thousand CAD | 0.0% |
| 2009 FY | 146.49 Thousand CAD | -38.72% |
| 2008 Q3 | 3.57 Million CAD | 8773.31% |
| 2008 Q4 | -3.42 Million CAD | -195.84% |
| 2008 Q2 | 40.31 Thousand CAD | -23.76% |
| 2008 Q1 | 52.87 Thousand CAD | -68.87% |
| 2008 FY | 239.06 Thousand CAD | -61.17% |
| 2007 Q3 | 75.22 Thousand CAD | -72.56% |
| 2007 Q2 | 274.08 Thousand CAD | 314.95% |
| 2007 Q1 | 66.05 Thousand CAD | 71.1% |
| 2007 FY | 615.68 Thousand CAD | -10.61% |
| 2007 Q4 | 169.83 Thousand CAD | 125.78% |
| 2006 Q3 | 74.11 Thousand CAD | -6.26% |
| 2006 Q4 | 38.6 Thousand CAD | -47.91% |
| 2006 Q1 | 476.16 Thousand CAD | 918.45% |
| 2006 Q2 | 79.06 Thousand CAD | -83.4% |
| 2006 FY | 688.77 Thousand CAD | 68.68% |
| 2005 Q2 | 51.56 Thousand CAD | -55.58% |
| 2005 Q4 | 46.75 Thousand CAD | -74.92% |
| 2005 FY | 408.32 Thousand CAD | 78.46% |
| 2005 Q3 | 186.45 Thousand CAD | 261.58% |
| 2005 Q1 | 116.08 Thousand CAD | 63.94% |
| 2004 Q4 | 70.81 Thousand CAD | 65.66% |
| 2004 Q3 | 42.74 Thousand CAD | -6.91% |
| 2004 Q2 | 45.91 Thousand CAD | -28.44% |
| 2004 FY | 228.8 Thousand CAD | -10.49% |
| 2004 Q1 | 64.16 Thousand CAD | -42.06% |
| 2003 Q1 | 56.15 Thousand CAD | -42.35% |
| 2003 Q2 | 45.32 Thousand CAD | -19.27% |
| 2003 Q3 | 38.75 Thousand CAD | -14.51% |
| 2003 Q4 | 110.75 Thousand CAD | 185.8% |
| 2003 FY | 255.6 Thousand CAD | 16.31% |
| 2002 Q1 | 36.8 Thousand CAD | 0.0% |
| 2002 FY | 219.76 Thousand CAD | 128.72% |
| 2002 Q2 | 43.35 Thousand CAD | 17.8% |
| 2002 Q4 | 97.39 Thousand CAD | 121.55% |
| 2002 Q3 | 43.96 Thousand CAD | 1.41% |
| 2001 FY | 96.08 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BioElectronics Corporation | 740.67 Thousand USD | 100.0% |
| IR-Med Inc. | 4.89 Million USD | 100.0% |
| Polarean Imaging plc | 12.24 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 100.0% |
| Avitar, Inc. | 3.56 Million USD | 100.0% |
| AVITA Medical, Inc. | 80.77 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| Zecotek Photonics Inc. | 3.46 Million USD | 100.0% |
| QHSLab, Inc. | 961.65 Thousand USD | 100.0% |
| Wellstar International, Inc. | 1.79 Million USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 100.0% |
| Escalon Medical Corp. | 5.25 Million USD | 100.0% |
| Aurora Spine Corporation | 8.65 Million USD | 100.0% |
| BrainsWay Ltd. | 28.01 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 9.56 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 100.0% |
| Vivos Inc. | 2.78 Million USD | 100.0% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 2.27 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 100.0% |
| Nanomix Corporation | 8.36 Million USD | 100.0% |
| Theraclion SA | 7.43 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 1.29 Million USD | 100.0% |
| Positron Corporation | 1 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 100.0% |
| Lombard Medical, Inc. | 30.29 Million USD | 100.0% |
| ALR Technologies Inc. | 6.33 Million USD | 100.0% |
| Stratec SE | 46.32 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.27 Million USD | 100.0% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 63.63 USD | 100.0% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 100.0% |
| Ingen Technologies, Inc. | 1.88 Million USD | 100.0% |
| Odyssey Group International, Inc. | -14.26 Million USD | 100.0% |
| United American Healthcare Corporation | 59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 100.0% |
| Urologix, Inc. | 10.09 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 100.0% |
| SS Innovations International, Inc. | 21.38 Million USD | 100.0% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 100.0% |
| Smith & Nephew plc | 3.46 Billion USD | 100.0% |
| NIOX Group Plc | 22.27 Million USD | 100.0% |
| Fuse Medical, Inc. | 10.35 Million USD | 100.0% |
| Broncus Holding Corporation | 38.15 Million USD | 100.0% |
| Brain Scientific Inc. | 9.66 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 100.0% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | 100.0% |